400-859-2883
Your location:Home >News center >Industry News

Industry News

05-232024

Re-Engineering IL-2 For Immuno-Oncology A…

IL-2 can be applied in both the field of anti-tumor therapy and the field of autoimmune disease treatment.

Re-Engineering IL-2 For Immuno-Oncology Applications
05-112024

PEG Derivatives for Long Acting rhG-CSF

G-CSFs have become the major therapeutic option for the treatment of patients with neutropenia.

PEG Derivatives for Long Acting rhG-CSF
04-302024

Peptide-Drug Conjugates Approvals and In …

Currently, there are only two PDCs approved for therapeutic use globally and 40+ PDCs in clinical trails.

Peptide-Drug Conjugates Approvals and In Clinical Trials
04-152024

The Status of Complement Inhibitor Resear…

Now, there are 14 complement inhibitors are approved by FDA, and 100+ in clinical trials.

The Status of Complement Inhibitor Research
03-272024

What Is Piroctone Olamine, Can It Get Rid…

Piroctone Olamine is an effective ingredient for controlling dandruff and promoting a healthy scalp.

What Is Piroctone Olamine, Can It Get Rid Of Dandruff?
03-132024

TROP-2 directed antibody-drug conjugates …

Trop2 has gained significant attention in antibody-drug conjugate (ADC) research as a potential therapeutic target due to its widespread expression in tumor tissues and limited expression in …

TROP-2 directed antibody-drug conjugates (ADCs) for cancer treatment
02-192024

Summary of ADC Targets for Breast Cancer

Some new ADC antigen targets for breast cancer, including Nectin-4, HER3, tissue factor (TF), FRα, LIV-1, ROR1-2, and B7-H4, etc.

Summary of ADC Targets for Breast Cancer
01-252024

Pro-xylane – Powerful Cosmetic Ingredien…

Pro-xylane, also known as hydroxyethyl tetrahydropyrantriol, is an anti-aging active substance that promotes the synthesis of collagen.

Pro-xylane – Powerful Cosmetic Ingredient
01-112024

Advances in Nonalcoholic Fatty Liver Dise…

The U.S. FDA has not yet approved any drugs for NASH treatment. The search for an effective and safe treatment for NASH is urgent.

Advances in Nonalcoholic Fatty Liver Disease (NAFLD) Treatment
12-262023

Molecular glues: Current Satus and Future…

What are molecular glues? What are advantages of molecular glues over PROTACs? And list of molecular glues approvals and in clinic trails.

Molecular glues: Current Satus and Future Development